Business Context and Reporting Period
Company: Microbot Medical Inc. (MBOT)
Filing Type: Form 8-K (Current Report)
Date of Report: April 22, 2026
Principal Executive Offices: Hingham, MA
The filing reports a Regulation FD disclosure regarding updated joint guidelines on occupational protection in interventional radiology released by the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Key Financial Metrics
This Form 8-K is a disclosure of a specific event and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No financial material changes are reported in this filing. The material event is the release of updated industry guidelines which the Company believes could strengthen the commercial position of its LIBERTY® Endovascular Robotic System.
Guidance, Outlook, and Management Commentary
- Management Commentary: The Company issued a press release (Exhibit 99.1) highlighting that the new guidelines provide safety guidance to physicians, radiographers, nurses, and medical physics experts.
- Outlook: Management suggests these guidelines may enhance the commercial prospects of the LIBERTY® system.
- Risks and Contingencies: No specific risks or contingencies are detailed in this filing beyond the standard disclaimer that the information is furnished and not "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review the full text of the SIR and CIRSE updated joint guidelines to assess the specific safety requirements mentioned.
- Verify the content of the press release furnished as Exhibit 99.1 to this 8-K.
- Monitor future filings for any quantifiable impact of these guidelines on the adoption or sales of the LIBERTY® Endovascular Robotic System.